Skip to main content
Top
Published in: Immunologic Research 2-3/2013

01-07-2013 | Etio Pathogenesis of Autoimmunity

Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity

Authors: C. A. Shaw, L. Tomljenovic

Published in: Immunologic Research | Issue 2-3/2013

Login to get access

Abstract

We have examined the neurotoxicity of aluminum in humans and animals under various conditions, following different routes of administration, and provide an overview of the various associated disease states. The literature demonstrates clearly negative impacts of aluminum on the nervous system across the age span. In adults, aluminum exposure can lead to apparently age-related neurological deficits resembling Alzheimer’s and has been linked to this disease and to the Guamanian variant, ALS–PDC. Similar outcomes have been found in animal models. In addition, injection of aluminum adjuvants in an attempt to model Gulf War syndrome and associated neurological deficits leads to an ALS phenotype in young male mice. In young children, a highly significant correlation exists between the number of pediatric aluminum-adjuvanted vaccines administered and the rate of autism spectrum disorders. Many of the features of aluminum-induced neurotoxicity may arise, in part, from autoimmune reactions, as part of the ASIA syndrome.
Literature
1.
go back to reference Exley C. Aluminium and medicine. In: Merce ALR, Felcman J, Recio MAL, editors. Molecular and supramolecular bioinorganic chemistry: applications in medical sciences. New York: Nova Biomedical Books; 2009. p. 45–68. Exley C. Aluminium and medicine. In: Merce ALR, Felcman J, Recio MAL, editors. Molecular and supramolecular bioinorganic chemistry: applications in medical sciences. New York: Nova Biomedical Books; 2009. p. 45–68.
3.
go back to reference Exley C, Korchazhkina O, Job D, Strekopytov S, Polwart A, Crome P. Non-invasive therapy to reduce the body burden of aluminium in Alzheimer’s disease. J Alzheimers Dis. 2006; 10(1): 17–24; discussion 29-31. Exley C, Korchazhkina O, Job D, Strekopytov S, Polwart A, Crome P. Non-invasive therapy to reduce the body burden of aluminium in Alzheimer’s disease. J Alzheimers Dis. 2006; 10(1): 17–24; discussion 29-31.
4.
go back to reference Exley C, House E. Aluminium in the human brain. Monatsh Chem. 2011;142:357–63.CrossRef Exley C, House E. Aluminium in the human brain. Monatsh Chem. 2011;142:357–63.CrossRef
5.
go back to reference Guillard O, Fauconneau B, Olichon D, Dedieu G, Deloncle R. Hyperaluminemia in a woman using an aluminum-containing antiperspirant for 4 years. Am J Med. 2004;117(12):956–9.PubMedCrossRef Guillard O, Fauconneau B, Olichon D, Dedieu G, Deloncle R. Hyperaluminemia in a woman using an aluminum-containing antiperspirant for 4 years. Am J Med. 2004;117(12):956–9.PubMedCrossRef
6.
go back to reference Lopes MM, Caldas LQA. Young children with autism spectrum disorders: can aluminium body burden cause metabolism disruption? Toxicol Lett. 2011;205S:S60–179. Lopes MM, Caldas LQA. Young children with autism spectrum disorders: can aluminium body burden cause metabolism disruption? Toxicol Lett. 2011;205S:S60–179.
7.
go back to reference Walton JR. Aluminum in hippocampal neurons from humans with Alzheimer’s disease. Neurotoxicol. 2006;27(3):385–94.CrossRef Walton JR. Aluminum in hippocampal neurons from humans with Alzheimer’s disease. Neurotoxicol. 2006;27(3):385–94.CrossRef
8.
go back to reference Gies WJ. Some objections to the use of alum baking-powder. JAMA. 1911;57(10):816–21.CrossRef Gies WJ. Some objections to the use of alum baking-powder. JAMA. 1911;57(10):816–21.CrossRef
9.
go back to reference Tomljenovic L. Aluminum and alzheimer’s disease: after a century of controversy, is there a plausible link? J Alzheimers Dis. 2011;23(4):567–98.PubMed Tomljenovic L. Aluminum and alzheimer’s disease: after a century of controversy, is there a plausible link? J Alzheimers Dis. 2011;23(4):567–98.PubMed
10.
go back to reference Exley C. Reflections upon and recent insight into the mechanism of formation of hydroxyaluminosilicates and the therapeutic potential of silicic acid. Coord Chem Rev. 2011;256(1–2):82–8. Exley C. Reflections upon and recent insight into the mechanism of formation of hydroxyaluminosilicates and the therapeutic potential of silicic acid. Coord Chem Rev. 2011;256(1–2):82–8.
12.
go back to reference Walton JR, Wang MX. APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer’s disease. J Inorg Biochem. 2009;103(11):1548–54.PubMedCrossRef Walton JR, Wang MX. APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer’s disease. J Inorg Biochem. 2009;103(11):1548–54.PubMedCrossRef
13.
go back to reference Burrell SA, Exley C. There is (still) too much aluminium in infant formulas. BMC Pediatr. 2010;10:63.PubMedCrossRef Burrell SA, Exley C. There is (still) too much aluminium in infant formulas. BMC Pediatr. 2010;10:63.PubMedCrossRef
14.
go back to reference Rogers MA, Simon DG. A preliminary study of dietary aluminium intake and risk of Alzheimer’s disease. Age Ageing. 1999;28(2):205–9.PubMedCrossRef Rogers MA, Simon DG. A preliminary study of dietary aluminium intake and risk of Alzheimer’s disease. Age Ageing. 1999;28(2):205–9.PubMedCrossRef
15.
16.
go back to reference Pivnick EK, Kerr NC, Kaufman RA, Jones DP, Chesney RW. Rickets secondary to phosphate depletion. A sequela of antacid use in infancy. Clin Pediatr (Phila). 1995;34(2):73–8.CrossRef Pivnick EK, Kerr NC, Kaufman RA, Jones DP, Chesney RW. Rickets secondary to phosphate depletion. A sequela of antacid use in infancy. Clin Pediatr (Phila). 1995;34(2):73–8.CrossRef
17.
go back to reference Dorea JG, Marques RC. Infants’ exposure to aluminum from vaccines and breast milk during the first 6 months. J Exp Sci Environ Epidemiol. 2010;20(7):598–601.CrossRef Dorea JG, Marques RC. Infants’ exposure to aluminum from vaccines and breast milk during the first 6 months. J Exp Sci Environ Epidemiol. 2010;20(7):598–601.CrossRef
18.
go back to reference Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorganic Biochem. 2011;105(11):1489–99.CrossRef Tomljenovic L, Shaw CA. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? J Inorganic Biochem. 2011;105(11):1489–99.CrossRef
19.
go back to reference Tomljenovic L, Shaw CA. Aluminum vaccine adjuvants: are they safe? Curr Medl Chem. 2011;18(17):2630–7.CrossRef Tomljenovic L, Shaw CA. Aluminum vaccine adjuvants: are they safe? Curr Medl Chem. 2011;18(17):2630–7.CrossRef
20.
go back to reference Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009;18(13):1217–25.PubMedCrossRef Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009;18(13):1217–25.PubMedCrossRef
21.
go back to reference Glenney AT, Pope CG, Waddington H, Wallace U. XXIII—the antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol. 1926;29:38–9. Glenney AT, Pope CG, Waddington H, Wallace U. XXIII—the antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol. 1926;29:38–9.
22.
go back to reference Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, Ranoux D, Pelletier J, Figarella-Branger D, Granel B, Maisonobe T, Coquet M, Degos JD, Gherardi RK. Central nervous system disease in patients with macrophagic myofasciitis. Brain. 2001;124(5):974–83.PubMedCrossRef Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, Ranoux D, Pelletier J, Figarella-Branger D, Granel B, Maisonobe T, Coquet M, Degos JD, Gherardi RK. Central nervous system disease in patients with macrophagic myofasciitis. Brain. 2001;124(5):974–83.PubMedCrossRef
23.
go back to reference Shaw CA, Höglinger GU. Neurodegenerative Diseases: neurotoxins as sufficient etiologic agents? J Neuromolec Med. 2008;10(1):1–9.CrossRef Shaw CA, Höglinger GU. Neurodegenerative Diseases: neurotoxins as sufficient etiologic agents? J Neuromolec Med. 2008;10(1):1–9.CrossRef
24.
go back to reference Kurland LT. Amyotrophic lateral sclerosis and Parkinson’s disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 1988;11(2):51–4.PubMedCrossRef Kurland LT. Amyotrophic lateral sclerosis and Parkinson’s disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 1988;11(2):51–4.PubMedCrossRef
25.
go back to reference Garruto RM, Swyt C, Fiori CE, Yanagihara R, Gadjusek DC. Intraneuronal deposition of calcium and aluminum in amyotrophic lateral sclerosis of Guam. Lancet. 1985;326:1353.CrossRef Garruto RM, Swyt C, Fiori CE, Yanagihara R, Gadjusek DC. Intraneuronal deposition of calcium and aluminum in amyotrophic lateral sclerosis of Guam. Lancet. 1985;326:1353.CrossRef
26.
go back to reference Shoenfeld Y, Agmon-Levin N. ‘ASIA’-Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8.PubMedCrossRef Shoenfeld Y, Agmon-Levin N. ‘ASIA’-Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8.PubMedCrossRef
27.
go back to reference Agmon-Levin N, Hughes G, Shoenfeld Y. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by adjuvants’. Lupus. 2012;21(2):118–20.PubMedCrossRef Agmon-Levin N, Hughes G, Shoenfeld Y. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by adjuvants’. Lupus. 2012;21(2):118–20.PubMedCrossRef
28.
go back to reference Fukuda K, Nisenbaum R, Stewart G. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA. 1998;280:981–8.PubMedCrossRef Fukuda K, Nisenbaum R, Stewart G. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA. 1998;280:981–8.PubMedCrossRef
29.
go back to reference Haley RW, Kurt TL, Hom J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA. 1997;277:215–22.PubMedCrossRef Haley RW, Kurt TL, Hom J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. JAMA. 1997;277:215–22.PubMedCrossRef
30.
go back to reference Fulco CE, Liverman CT, Sox HC. Gulf War and health: volume 1. Depleted uranium, pyridostigmine, bromide, sarin, and vaccines. Institute of Medicine. National Academy Press, 2000, p. 89–168. Fulco CE, Liverman CT, Sox HC. Gulf War and health: volume 1. Depleted uranium, pyridostigmine, bromide, sarin, and vaccines. Institute of Medicine. National Academy Press, 2000, p. 89–168.
31.
go back to reference Shawky S. Depleted uranium: an overview of its properties and health effects. East Mediterr Health J. 2002;8:432–9.PubMed Shawky S. Depleted uranium: an overview of its properties and health effects. East Mediterr Health J. 2002;8:432–9.PubMed
32.
go back to reference Kalra R, Singh SP, Razani-Boroujerdi S. Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system. Toxicol Appl Pharmacol. 2002;184:82–7.PubMedCrossRef Kalra R, Singh SP, Razani-Boroujerdi S. Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system. Toxicol Appl Pharmacol. 2002;184:82–7.PubMedCrossRef
33.
34.
go back to reference Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from co-exposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health. 1996;48:35–56.PubMedCrossRef Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from co-exposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures. J Toxicol Environ Health. 1996;48:35–56.PubMedCrossRef
35.
go back to reference Kurt TL. Epidemiological association in US veterans between Gulf War illness and exposures to anticholinesterases. Toxicol Lett. 1998;102–103:523–6.PubMedCrossRef Kurt TL. Epidemiological association in US veterans between Gulf War illness and exposures to anticholinesterases. Toxicol Lett. 1998;102–103:523–6.PubMedCrossRef
36.
go back to reference Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ. 2000;320:1363–7.PubMedCrossRef Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ. 2000;320:1363–7.PubMedCrossRef
37.
go back to reference Ferguson E, Cassaday HJ. Theoretical accounts of Gulf War Syndrome: from environmental toxins to psychoneuroimmunology and neurodegeneration. Behav Neurol Behav Neurol. 2001;13:133–47. Ferguson E, Cassaday HJ. Theoretical accounts of Gulf War Syndrome: from environmental toxins to psychoneuroimmunology and neurodegeneration. Behav Neurol Behav Neurol. 2001;13:133–47.
38.
go back to reference Nicolson GL, Nasralla MY, Haier J, Pomfret J. High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with Amyotrophic Lateral Sclerosis (ALS). J Clin Neurosci. 2002;9(525–529):131. Nicolson GL, Nasralla MY, Haier J, Pomfret J. High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with Amyotrophic Lateral Sclerosis (ALS). J Clin Neurosci. 2002;9(525–529):131.
39.
go back to reference Taylor DN, Sanchez JL, Smoak BL, DeFraites R. Helicobacter pylori infection in Desert Storm troops. Clin Infect Dis. 1997;25:979–82.PubMedCrossRef Taylor DN, Sanchez JL, Smoak BL, DeFraites R. Helicobacter pylori infection in Desert Storm troops. Clin Infect Dis. 1997;25:979–82.PubMedCrossRef
40.
go back to reference Nass M. Anthrax vaccine. Model of a response to the biologic warfare threat. Infect Dis Clin North Am. 1999;13:VIII187–208.CrossRef Nass M. Anthrax vaccine. Model of a response to the biologic warfare threat. Infect Dis Clin North Am. 1999;13:VIII187–208.CrossRef
41.
go back to reference Unwin C, Blatchley N, Coker W. Health of UK servicemen who served in the Persian Gulf War. Lancet. 1999;353:169–78.PubMedCrossRef Unwin C, Blatchley N, Coker W. Health of UK servicemen who served in the Persian Gulf War. Lancet. 1999;353:169–78.PubMedCrossRef
42.
go back to reference Salamon R, Verret C, Jutand MA. Health consequences of the first Persian Gulf War on French troops. Int J Epidemiol. 2006;35:479–87.PubMedCrossRef Salamon R, Verret C, Jutand MA. Health consequences of the first Persian Gulf War on French troops. Int J Epidemiol. 2006;35:479–87.PubMedCrossRef
43.
go back to reference Petrik MS, Wong MC, Tabata RC, Garry RF, Shaw CA. Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. J Neuromolec Med. 2007;9(1):83–100.CrossRef Petrik MS, Wong MC, Tabata RC, Garry RF, Shaw CA. Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. J Neuromolec Med. 2007;9(1):83–100.CrossRef
44.
go back to reference Shaw CA, Petrik MS. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem. 2009;103(11):1555–62.PubMedCrossRef Shaw CA, Petrik MS. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem. 2009;103(11):1555–62.PubMedCrossRef
45.
go back to reference Luján L, Pérez M, Salazar E, Gimeno M, Pinczowski P, Irusta S, Santamaria J, Fantova E, Vila M, Gracia Chapulle, JL (2012) An ovine neurodegenerative syndrome associated to repetitive vaccine administration. 8th international autoimmunity congress. Granada, Spain. Luján L, Pérez M, Salazar E, Gimeno M, Pinczowski P, Irusta S, Santamaria J, Fantova E, Vila M, Gracia Chapulle, JL (2012) An ovine neurodegenerative syndrome associated to repetitive vaccine administration. 8th international autoimmunity congress. Granada, Spain.
46.
go back to reference Gherardi R, Authier FJ. Macrophagic myofasciitis: characterization and pathophysiology. Lupus. 2012;21(2):184–9.PubMedCrossRef Gherardi R, Authier FJ. Macrophagic myofasciitis: characterization and pathophysiology. Lupus. 2012;21(2):184–9.PubMedCrossRef
47.
go back to reference Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, Pellissier JF, Chariot P, Authier FJ. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain. 2001;124(Pt 9):1821–31.PubMedCrossRef Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, Pellissier JF, Chariot P, Authier FJ. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain. 2001;124(Pt 9):1821–31.PubMedCrossRef
48.
go back to reference Perl DP, Brody AR. Alzheimer’s disease: x-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 1980;208(4441):297–9.PubMedCrossRef Perl DP, Brody AR. Alzheimer’s disease: x-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 1980;208(4441):297–9.PubMedCrossRef
49.
go back to reference Altmann P. Aluminium induced disease in subjects with and without renal failure-does it help us understand the role of aluminium in Alzheimer’s Disease? In: Exley C, editor. Aluminium and Alzheimer’s Disease: The science that describes the link. Amsterdam: Elsevier Science; 2001. p. 1–37.CrossRef Altmann P. Aluminium induced disease in subjects with and without renal failure-does it help us understand the role of aluminium in Alzheimer’s Disease? In: Exley C, editor. Aluminium and Alzheimer’s Disease: The science that describes the link. Amsterdam: Elsevier Science; 2001. p. 1–37.CrossRef
50.
go back to reference Alfrey AC. Dialysis encephalopathy. Kidney Int Suppl. 1986;18:S53–7.PubMed Alfrey AC. Dialysis encephalopathy. Kidney Int Suppl. 1986;18:S53–7.PubMed
51.
go back to reference Flendrig JA, Kruis H, Das HA. Aluminium intoxication: the cause of dialysis dementia? Proc Eur Dial Transplant Assoc. 1976;13:355–68. Flendrig JA, Kruis H, Das HA. Aluminium intoxication: the cause of dialysis dementia? Proc Eur Dial Transplant Assoc. 1976;13:355–68.
52.
go back to reference Wills MR, Savory J. Water content of aluminum, dialysis dementia, and osteomalacia. Environ Health Perspect. 1985;63:141–7.PubMedCrossRef Wills MR, Savory J. Water content of aluminum, dialysis dementia, and osteomalacia. Environ Health Perspect. 1985;63:141–7.PubMedCrossRef
53.
go back to reference Edwardson JA, Candy JM, Ince PG, McArthur FK, Morris CM, Oakley AE, Taylor GA, Bjertness E. (1992) Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Found Symp 169: 165–179; Discussion 179-185. Edwardson JA, Candy JM, Ince PG, McArthur FK, Morris CM, Oakley AE, Taylor GA, Bjertness E. (1992) Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Found Symp 169: 165–179; Discussion 179-185.
54.
go back to reference Harrington CR, Wischik CM, McArthur FK, Taylor GA, Edwardson JA, Candy JM. Alzheimer’s-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet. 1994;343(8904):993–7.PubMedCrossRef Harrington CR, Wischik CM, McArthur FK, Taylor GA, Edwardson JA, Candy JM. Alzheimer’s-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet. 1994;343(8904):993–7.PubMedCrossRef
55.
go back to reference Flaten TP. Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull. 2001;55(2):187–96.PubMedCrossRef Flaten TP. Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull. 2001;55(2):187–96.PubMedCrossRef
56.
go back to reference McLachlan DRC, Bergeron C, Smith JE, Boomer D, Rifat SL. Risk for neuropathologically confirmed Alzheimer’s disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology. 1996;46(2):401–5.PubMedCrossRef McLachlan DRC, Bergeron C, Smith JE, Boomer D, Rifat SL. Risk for neuropathologically confirmed Alzheimer’s disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology. 1996;46(2):401–5.PubMedCrossRef
57.
go back to reference Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF. Relation between aluminum concentrations in drinking water and Alzheimer’s disease: an 8-year follow-up study. Am J Epidemiol. 2000;152(1):59–66.PubMedCrossRef Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF. Relation between aluminum concentrations in drinking water and Alzheimer’s disease: an 8-year follow-up study. Am J Epidemiol. 2000;152(1):59–66.PubMedCrossRef
58.
go back to reference Martyn CN, Barker DJ, Osmond C, Harris EC, Edwardson JA, Lacey RF. Geographical relation between Alzheimer’s disease and aluminum in drinking water. Lancet. 1989;1(8629):59–62.PubMed Martyn CN, Barker DJ, Osmond C, Harris EC, Edwardson JA, Lacey RF. Geographical relation between Alzheimer’s disease and aluminum in drinking water. Lancet. 1989;1(8629):59–62.PubMed
59.
go back to reference Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol. 2009;169(4):489–96.PubMedCrossRef Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol. 2009;169(4):489–96.PubMedCrossRef
60.
go back to reference Jacqmin-Gadda H, Commenges D, Letenneur L, Dartigues JF. Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiol. 1996;7(3):281–5.CrossRef Jacqmin-Gadda H, Commenges D, Letenneur L, Dartigues JF. Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiol. 1996;7(3):281–5.CrossRef
61.
go back to reference Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res. 2004;75(4):565–72.PubMedCrossRef Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res. 2004;75(4):565–72.PubMedCrossRef
62.
go back to reference Walton JR. Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. Neurotoxicol. 2009;30(2):182–93.CrossRef Walton JR. Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. Neurotoxicol. 2009;30(2):182–93.CrossRef
63.
go back to reference Platt B, Fiddler G, Riedel G, Henderson Z. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull. 2001;55(2):257–67.PubMedCrossRef Platt B, Fiddler G, Riedel G, Henderson Z. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull. 2001;55(2):257–67.PubMedCrossRef
64.
go back to reference Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, Reynolds AM, Rice CE, Schendel D, Windham GC. The epidemiology of autism spectrum disorders. Annu Rev Public Health. 2007;28:235–58.PubMedCrossRef Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, Reynolds AM, Rice CE, Schendel D, Windham GC. The epidemiology of autism spectrum disorders. Annu Rev Public Health. 2007;28:235–58.PubMedCrossRef
65.
go back to reference King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009;38(5):1224–34.PubMedCrossRef King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009;38(5):1224–34.PubMedCrossRef
66.
go back to reference Newschaffer CJ, Falb MD, Gurney JG. National autism prevalence trends from United States special education data. Pediatrics. 2005;115(3):e277–82.PubMedCrossRef Newschaffer CJ, Falb MD, Gurney JG. National autism prevalence trends from United States special education data. Pediatrics. 2005;115(3):e277–82.PubMedCrossRef
67.
go back to reference Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity in pediatric populations. Lupus. 2012;21(2):223–30.PubMedCrossRef Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity in pediatric populations. Lupus. 2012;21(2):223–30.PubMedCrossRef
68.
go back to reference Dorea JG. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines. Neurochem Res. 2011;36(6):927–38.PubMedCrossRef Dorea JG. Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines. Neurochem Res. 2011;36(6):927–38.PubMedCrossRef
69.
go back to reference Dorea JG, Marques RC, Brandao KG. Neonate exposure to thimerosal mercury from hepatitis B vaccines. Am J Perinatol. 2009;26(7):523–7.PubMedCrossRef Dorea JG, Marques RC, Brandao KG. Neonate exposure to thimerosal mercury from hepatitis B vaccines. Am J Perinatol. 2009;26(7):523–7.PubMedCrossRef
70.
go back to reference Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses. 2001;56(4):462–71.PubMedCrossRef Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses. 2001;56(4):462–71.PubMedCrossRef
71.
go back to reference Geier DA, Geier MR. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett. 2006;27(4):401–13.PubMed Geier DA, Geier MR. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett. 2006;27(4):401–13.PubMed
72.
go back to reference Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci. 2008;271(1–2):110–8.PubMedCrossRef Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci. 2008;271(1–2):110–8.PubMedCrossRef
73.
go back to reference Hewitson L, Houser LA, Stott C, Sackett G, Tomko JL, Atwood D, Blue L, White ER. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. J Toxicol Environ Health A. 2010;73(19):1298–313.PubMedCrossRef Hewitson L, Houser LA, Stott C, Sackett G, Tomko JL, Atwood D, Blue L, White ER. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. J Toxicol Environ Health A. 2010;73(19):1298–313.PubMedCrossRef
74.
go back to reference Gallagher CM, Goodman MS. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997–2002. J Toxicol Environ Health A. 2010;73(24):1665–77.PubMedCrossRef Gallagher CM, Goodman MS. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997–2002. J Toxicol Environ Health A. 2010;73(24):1665–77.PubMedCrossRef
75.
go back to reference Baylor NW, Egan W, Richman P. Aluminum salts in vaccines-US perspective. Vaccine. 2002;20(Suppl 3):S18–23.PubMedCrossRef Baylor NW, Egan W, Richman P. Aluminum salts in vaccines-US perspective. Vaccine. 2002;20(Suppl 3):S18–23.PubMedCrossRef
76.
go back to reference Rhawn J (1996) Normal and abnormal amygdala development, neuropsychiatry, neuropsychology, and clinical neuroscience. Lippincott Williams & Wilkins. Rhawn J (1996) Normal and abnormal amygdala development, neuropsychiatry, neuropsychology, and clinical neuroscience. Lippincott Williams & Wilkins.
77.
go back to reference Gunnar MR, Brodersen L, Krueger K, Rigatuso J. Dampening of adrenocortical responses during infancy: normative changes and individual differences. Child Dev. 1996;67(3):877–89.PubMedCrossRef Gunnar MR, Brodersen L, Krueger K, Rigatuso J. Dampening of adrenocortical responses during infancy: normative changes and individual differences. Child Dev. 1996;67(3):877–89.PubMedCrossRef
78.
go back to reference Balaban-Gil K, Tuchman R. Epilepsy and epileptiform EEG: association with autism and language disorders. Ment Retard Dev Disabil Res Rev. 2000;6(4):300–8.CrossRef Balaban-Gil K, Tuchman R. Epilepsy and epileptiform EEG: association with autism and language disorders. Ment Retard Dev Disabil Res Rev. 2000;6(4):300–8.CrossRef
79.
go back to reference Polimeni MA, Richdale AL, Francis AJ. A survey of sleep problems in autism, Asperger’s disorder and typically developing children. J Intellect Disabil Res. 2005;49(Pt 4):260–8.PubMedCrossRef Polimeni MA, Richdale AL, Francis AJ. A survey of sleep problems in autism, Asperger’s disorder and typically developing children. J Intellect Disabil Res. 2005;49(Pt 4):260–8.PubMedCrossRef
80.
go back to reference Porges SW. The vagus: a mediator of behavioral and physiologic features associated with autism. In: Bauman ML, Kemper TL, editors. The Neurobiology of Autism Baltimore. Maryland: The Johns Hopkins University Press; 2005. p. 65–78. Porges SW. The vagus: a mediator of behavioral and physiologic features associated with autism. In: Bauman ML, Kemper TL, editors. The Neurobiology of Autism Baltimore. Maryland: The Johns Hopkins University Press; 2005. p. 65–78.
81.
go back to reference Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.PubMed Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.PubMed
82.
83.
go back to reference Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg Biochem. 2009;103(11):1571–8.PubMedCrossRef Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg Biochem. 2009;103(11):1571–8.PubMedCrossRef
84.
go back to reference Exley C, Swarbrick L, Gherardi RK, Authier FJ. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses. 2009;72(2):135–9.PubMedCrossRef Exley C, Swarbrick L, Gherardi RK, Authier FJ. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses. 2009;72(2):135–9.PubMedCrossRef
85.
go back to reference Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y. Autoimmunity following Hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (ASIA): analysis of 93 cases. Lupus. 2012;21(2):146–52.PubMedCrossRef Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y. Autoimmunity following Hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (ASIA): analysis of 93 cases. Lupus. 2012;21(2):146–52.PubMedCrossRef
86.
go back to reference Redhead K, Quinlan GJ, Das RG, Gutteridge JM. Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue. Pharmacol Toxicol. 1992;70(4):278–80.PubMedCrossRef Redhead K, Quinlan GJ, Das RG, Gutteridge JM. Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue. Pharmacol Toxicol. 1992;70(4):278–80.PubMedCrossRef
87.
go back to reference Offit PA, Jew RK. Addressing parents’ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics. 2003;112(6 Pt 1):1394–7.PubMedCrossRef Offit PA, Jew RK. Addressing parents’ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics. 2003;112(6 Pt 1):1394–7.PubMedCrossRef
88.
go back to reference Yokel RA, Hicks CL, Florence RL. Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese. Food Chem Toxicol. 2008;46(6):2261–6.PubMedCrossRef Yokel RA, Hicks CL, Florence RL. Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese. Food Chem Toxicol. 2008;46(6):2261–6.PubMedCrossRef
89.
go back to reference Yokel RA, McNamara PJ. Aluminium toxicokinetics: an updated minireview. Pharmacol Toxicol. 2001;88(4):159–67.PubMedCrossRef Yokel RA, McNamara PJ. Aluminium toxicokinetics: an updated minireview. Pharmacol Toxicol. 2001;88(4):159–67.PubMedCrossRef
90.
go back to reference Dillon SB, Demuth SG, Schneider MA, Weston CB, Jones CS, Young JF, Scott M, Bhatnaghar PK, LoCastro S, Hanna N. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine. 1992;10(5):309–18.PubMedCrossRef Dillon SB, Demuth SG, Schneider MA, Weston CB, Jones CS, Young JF, Scott M, Bhatnaghar PK, LoCastro S, Hanna N. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine. 1992;10(5):309–18.PubMedCrossRef
91.
go back to reference Seubert A, Monaci E, Pizza M, O’Hagan DT, Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol. 2008;180(8):5402–12.PubMed Seubert A, Monaci E, Pizza M, O’Hagan DT, Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol. 2008;180(8):5402–12.PubMed
92.
go back to reference Quiroz-Rothe EP, Ginel PJ, Pérez J, Lucena R, Rivero JLL. Vaccine-associated acute polyneuropathy resembling Guillain-Barré syndrome in a dog. EJCAP. 2005;15(2):155–9. Quiroz-Rothe EP, Ginel PJ, Pérez J, Lucena R, Rivero JLL. Vaccine-associated acute polyneuropathy resembling Guillain-Barré syndrome in a dog. EJCAP. 2005;15(2):155–9.
93.
go back to reference Batista-Duharte A, Lindblad EB, Oviedo-Orta E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett. 2011;203(2):97–105.PubMedCrossRef Batista-Duharte A, Lindblad EB, Oviedo-Orta E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett. 2011;203(2):97–105.PubMedCrossRef
95.
go back to reference Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol. 2002;129(1–2):168–77.PubMedCrossRef Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol. 2002;129(1–2):168–77.PubMedCrossRef
96.
go back to reference Banks WA, Kastin AJ. Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier. Neurosci Biobehav Rev. 1989;13(1):47–53.PubMedCrossRef Banks WA, Kastin AJ. Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier. Neurosci Biobehav Rev. 1989;13(1):47–53.PubMedCrossRef
97.
go back to reference Zheng W. Neurotoxicology of the brain barrier system: new implications. J Toxicol Clin Toxicol. 2001;39(7):711–9.PubMedCrossRef Zheng W. Neurotoxicology of the brain barrier system: new implications. J Toxicol Clin Toxicol. 2001;39(7):711–9.PubMedCrossRef
98.
go back to reference Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis. 2006;10(2–3):223–53.PubMed Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis. 2006;10(2–3):223–53.PubMed
99.
go back to reference Prat AK, Biernacki K, Wosik K, Antel JP. Glial cell influence on the human blood–brain barrier. Glia. 2001;36:145–55. Prat AK, Biernacki K, Wosik K, Antel JP. Glial cell influence on the human blood–brain barrier. Glia. 2001;36:145–55.
100.
go back to reference Aydin H, Ozgul E, Agildere AM. Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination:diffusion-weighted imaging and proton MR spectroscopy findings. Pediatr Radiol. 2010;40:1281–4.PubMedCrossRef Aydin H, Ozgul E, Agildere AM. Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination:diffusion-weighted imaging and proton MR spectroscopy findings. Pediatr Radiol. 2010;40:1281–4.PubMedCrossRef
101.
go back to reference Hogenesch H, Azcona-Olivera J, Scott-Moncrieff C, Snyder PW, Glickman LT. Vaccine-induced autoimmunity in the dog. Adv Vet Med. 1999;41:733–47.PubMedCrossRef Hogenesch H, Azcona-Olivera J, Scott-Moncrieff C, Snyder PW, Glickman LT. Vaccine-induced autoimmunity in the dog. Adv Vet Med. 1999;41:733–47.PubMedCrossRef
102.
go back to reference Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-’vaccinosis’: a dangerous liaison?”. J Autoimmun. 2000;14(1):1–10.PubMedCrossRef Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-’vaccinosis’: a dangerous liaison?”. J Autoimmun. 2000;14(1):1–10.PubMedCrossRef
103.
go back to reference Passeri E, Villa C, Maryline C, Itti E, Brugieres P, Cesaro P, Gherardi RK, Bachoud-Levi A-C. Authier F-J (2011) Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF). J Inorg Biochem. 2011;105(11):1457–63.PubMedCrossRef Passeri E, Villa C, Maryline C, Itti E, Brugieres P, Cesaro P, Gherardi RK, Bachoud-Levi A-C. Authier F-J (2011) Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF). J Inorg Biochem. 2011;105(11):1457–63.PubMedCrossRef
Metadata
Title
Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity
Authors
C. A. Shaw
L. Tomljenovic
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Immunologic Research / Issue 2-3/2013
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-013-8403-1

Other articles of this Issue 2-3/2013

Immunologic Research 2-3/2013 Go to the issue